The FDA pulls key DEI initiative for cancer studies from its website
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...
The American Journal of Managed Care2h
FDA Approves First HER2-Ultralow Companion Diagnostic, Expanding Treatment Eligibility
Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...
Exclusive: Cowboys QB Dak Prescott supports effort to get cancer test covered by Medicare
Bill to pay for multi-cancer early detection screening test has bipartisan support, but just ran out of time last session.
'No data' on health risks: Japan keeps Red No. 3 dye legal despite FDA ban
Japan's Consumer Affairs Agency (CAA) has stated there is "no data" showing health hazards from the food dye Red No. 3, which ...
New Atlas15h
"Kick and kill": HIV cure could be hiding in FDA-approved drug
HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...
Cure Today3d
FDA Approves Enhertu for HER2-Low and -Ultralow Breast Cancer
The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...
Could the FDA's recently approved Pap smear alternative reduce racial disparities in cervical cancer deaths?
Northwell Health partnered with Stacker to explore how a new Pap smear alternative may help prevent deaths from cervical ...
Healio3d
FDA expands Enhertu approval for breast cancer
The FDA expanded the approval of trastuzumab deruxtecan for treatment of breast cancer.The new indication applies to use of ...
Health Rounds: Old anti-inflammatory may delay colon cancer recurrence
Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...
Targeted Oncology4d
FDA Approves T-DXd in HR+, HER2-Low/Ultralow Breast Cancer
The FDA approved trastuzumab deruxtecan for adult patients with unresectable or metastatic HER2-low or HER2-ultralow breast ...
JD Supra4h
FDA Bans Red Dye No. 3 in Food and Ingested Drugs: What Manufacturers Should Know
On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...